Overview

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
A randomised, double-blind, 3-arm parallel group study comparing Aricept® with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Limited
Treatments:
Donepezil